← Back to Analyst Consensus 
APMD Buy
Apnimed, Inc.
Current Price —
Implied Upside —
Analysts 10
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 25, 2026 | LifeSci Capital | initiate | — → Outperform | — | 57% |
| Aug 25, 2026 | Cantor Fitzgerald | initiate | — → Overweight | — | 50% |
| Aug 25, 2026 | Evercore ISI Group | initiate | — → Outperform | — | 58% |
| Aug 25, 2026 | B of A Securities | initiate | — → Buy | — | 53% |
Price Target Trend
Aug 29, 2026 Oct 26, 2026
EPS Estimates
+1q —
0y —
0q —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days